BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America
Share:
Email this page Share this on LinkedIn Share this on Twitter

Advisors

Kees Been Kees Been
President and CEO
Lysosomal Therapeutics Inc.
Bruce Booth Bruce Booth
Partner
Atlas Venture
Richard Brudnick Richard Brudnick
VP, Co-Head BD/M&A
Biogen Idec
David Collier David Collier
CEO
Velocity Pharmaceutical Development
Stuart Collinson Stuart Collinson
CEO
Tioga Pharmaceuticals
Pamela Demain Pamela Demain
Executive Director
Corporate Licensing
Merck & Co. Inc.
Steven Dickman Steven Dickman
CEO
CBT Advisors
John Hallinan John Hallinan
Chief Business Officer
MassBio
Tomas Landh Tomas Landh
Director, Strategy and Innovation Sourcing, Diabetes Research Unit
Novo Nordisk
Philippe Lopes-Fernandes Philippe Lopes-Fernandes
Senior VP and Head,
Global Licensing and Business Development
EMD Serono
Douglas MacDougall Douglas MacDougall
President
MacDougall Biomedical Communications
Michal Preminger Michal Preminger
Executive Director
Office of Technology Development
Harvard University
Dennis  Purcell Dennis Purcell
Senior Managing Director
Aisling Capital
Greg Robinson Greg Robinson
Senior Director
Scientific Licensing Assessment
Shire Human Genetic Therapies
Morrie Ruffin Morrie Ruffin
Managing Partner
Adjuvant Partners
Kumar Srinivasan Kumar Srinivasan
VP, Scientific Partnering and Alliances
AstraZeneca
Daphne Zohar Daphne Zohar
Founder, Managing Partner
PureTech Ventures
Arrow Up


© 2009–2014 EBD Group, Inc.
BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America